![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Agranulocytosis - 258 Studies Found
Completed |
: A Study of Empirical Antifungal Therapy With Itraconazole : Neutropenia : 2012-10-11 : Drug: Itraconazole Itraconazole intravenous (IV) 200 mg twice daily for 2 days, a total of 4 doses and t |
Completed |
: Phase III Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia : Chemotherapy Induced Neutropenia : 2012-01-19 :
|
Completed |
: The Utility of Multiplex PCR for Detection of DNA in Neutropenic Patients With Hematological Malignancies : Neutropenia : 2012-08-16 |
Completed |
: Effectiveness of Reduced GCSF Dosing in Patients With a Low to Moderate Risk of Febrile Neutropenia : Breast Cancer : 2012-07-27 : Drug: GCSF administration on days 8 and 12 after chemotherapy |
Completed |
: Pharmacokinetics and Pharmacodynamics Study of Pegfilgrastim in Chemotherapy Patients : Neutropenia : 2012-07-02 : Drug: Pegfilgrastim Single SC injection of the appropriate dose of drug ranging from 30 mcg/kg to 200 mc |
Completed |
: Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents :
|
Completed |
: Prevention of Neutropenia After Using G-CSF With TAC Chemotherapy : Neutropenia : 2012-03-29 :
|
Completed |
: Micafungin Prevention Study for Invasive Fungal Disease in Pediatric & Adolescent Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation :
: 2011-08-09 : Drug: micafungin Eligible patients who provided informed consent form will be administered micafungin at |
Completed |
: GCPGC in Chemotherapy-induced Neutropenia : Chemotherapy Induced Neutropenia : 2011-02-06 :
|
Terminated |
: SubCutaneous (SC) Versus Intravenous (IV) Granulocyte Colony Stimulating Factors (G-CSF) for the Treatment of Neutropenia in Hospitalized Haemato-oncological Patients : Leukemia : 2010-10-14 : Drug: filgrastim 5 mcg/kg (rounded to 300 mcg or 480 mcg) |